Surojit Sur is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of liver fibrosis. With a total of 4 patents to his name, Sur is recognized for his innovative approaches to addressing this serious health condition.

Latest Patents

One of Surojit Sur's latest patents focuses on methods of treating liver fibrosis by administering 3-bromopyruvate. This patent outlines methods for treating or preventing liver fibrosis in a subject by administering a therapeutically effective amount of 3-bromopyruvate (3-BrPA). Additionally, it provides methods for promoting the reversal of activated hepatic stellate cells (HSC) to inactivated HSC by contacting the activated HSC with at least one 3-bromopyruvate (3-BrPA) molecule.

Career Highlights

Surojit Sur is affiliated with Johns Hopkins University, where he conducts his research and develops his innovative treatments. His work has garnered attention in the medical community, contributing to advancements in liver disease therapies.

Collaborations

Sur has collaborated with notable colleagues, including Jean-Francois Geschwind and Shanmugasundaram Ganapathy-Kanniappan. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Surojit Sur's contributions to the treatment of liver fibrosis through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire and pave the way for future research in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.